Night Waking and Hormones: What Could Be Causing It

Why Hormones Disrupt Sleep in Women

Women experience sleep disruption at roughly twice the rate of men across the lifespan, and hormonal biology is a central reason. Sleep is not a passive state. Estrogen promotes serotonin and norepinephrine activity, stabilizes thermoregulation, and increases REM duration. Progesterone acts on GABA-A receptors in the brain, producing a mild sedative effect and supporting slow-wave sleep. When either hormone drops or fluctuates rapidly, the architecture of your night changes in ways that are measurable on polysomnography.

Research published in Sleep Medicine Reviews shows that women report more sleep-maintenance insomnia (waking after sleep onset) than sleep-onset insomnia, and this pattern aligns with hormonal mechanisms rather than purely psychological ones. The key distinction for your clinician is whether you fall asleep easily but wake repeatedly, or whether you cannot get to sleep at all. The former is more often hormonal.

How Sex Hormones Regulate Sleep Architecture

Estradiol, the dominant estrogen in reproductive years, modulates the hypothalamic thermostat. A drop in estradiol narrows the thermoneutral zone, meaning your body triggers heat-loss responses (sweating, peripheral vasodilation) at a lower threshold. That vasomotor event pulls you from deep sleep into lighter stages or full waking.

Progesterone acts differently. It metabolizes into allopregnanolone, a neurosteroid that binds GABA-A receptors. A study in the Journal of Clinical Endocrinology and Metabolism confirmed that allopregnanolone levels correlate with slow-wave sleep duration. When progesterone falls, whether at the end of your luteal phase, postpartum, or during perimenopause, that GABA-A sedation disappears and lighter, more fragmented sleep follows.

Cortisol and the 2 a.m. Wake

Cortisol follows a 24-hour rhythm, rising steeply in the early morning (the cortisol awakening response) and staying low overnight. In women with chronic stress, HPA axis dysregulation, or subclinical adrenal issues, that overnight nadir can be disrupted. Nocturnal cortisol spikes pull you into wakefulness, often between 2 and 4 a.m., with a racing heart or a sense of alertness that feels misplaced at that hour. This pattern is distinct from the hot-flash waking of perimenopause, though both can coexist.

Night Waking Across Your Life Stage

Reproductive Years: Cycle-Linked Waking

If you are in your 20s or 30s and notice your worst nights cluster in the week before your period, the luteal phase is the likely culprit. Progesterone peaks at approximately day 21 of a 28-day cycle, then falls sharply if conception does not occur. One study in Sleep documented that women have significantly less slow-wave sleep and more wakefulness in the late luteal phase compared to the follicular phase.

Women with PCOS have additional disruption. Androgen excess, insulin resistance, and altered LH pulsatility all perturb sleep, and research in Human Reproduction found that women with PCOS have a three-fold higher prevalence of obstructive sleep apnea compared to weight-matched controls without PCOS. Sleep apnea causes its own arousals, and it is frequently missed in women because their presentations differ from the classic male pattern.

Trying to Conceive

During ovarian stimulation or timed intercourse cycles, exogenous progesterone supplementation (common as luteal support) can actually improve sleep quality for some women and cause vivid dreams or early waking in others. If you are doing IVF and sleeping poorly on progesterone suppositories or injections, that is a direct pharmacological effect worth discussing with your reproductive endocrinologist.

Pregnancy

Night waking in pregnancy is nearly universal and is not simply explained by physical discomfort. In the first trimester, rising progesterone causes daytime sleepiness but also fragments nighttime sleep. By the third trimester, data from the AJOG show that up to 97% of women report sleep disturbance, driven by nocturia, fetal movement, restless legs (which worsens with iron deficiency common in pregnancy), and reduced REM due to hormonal shifts.

Restless legs syndrome (RLS) affects approximately 26% of pregnant women compared to 3% of the general population, per CDC epidemiological data. Iron and folate deficiency drive this. Treatment is largely non-pharmacological in pregnancy (iron repletion, stretching, magnesium), because most pharmacological RLS agents lack adequate safety data in pregnancy.

Postpartum

The postpartum period involves one of the most abrupt hormonal drops a woman experiences: estrogen and progesterone plummet within 24 hours of delivery. This drop, combined with newborn feeding demands, makes postpartum sleep architecture chaotic. But even women whose infants sleep through the night from early on can continue to experience fragmented sleep for months. Research in Sleep Medicine shows that maternal slow-wave sleep remains suppressed for at least 12 weeks postpartum independent of feeding frequency, likely due to prolonged hormonal normalization.

If you are breastfeeding, prolactin is elevated and this has a mild sleep-promoting effect, which partially explains why exclusively breastfeeding women sometimes report better subjective sleep than formula-feeding mothers despite more nighttime feeds. Still, prolactin does not fully compensate for the loss of progesterone's sedative action.

Perimenopause: The Peak of Hormonal Sleep Disruption

Perimenopause is the life stage where hormonal sleep disruption is most intense and most prolonged. It begins, on average, four years before the final menstrual period, but the sleep impact can start a decade earlier for some women. The Study of Women's Health Across the Nation (SWAN) followed over 3,000 women and found that sleep difficulty increased significantly as women moved from premenopause into perimenopause, with the strongest predictor being vasomotor symptom frequency.

The mechanism is layered. Estradiol levels become erratic rather than simply low, swinging widely cycle to cycle. These swings destabilize thermoregulation more than a consistently low estradiol would. Hot flashes trigger full arousals multiple times per night. One flash does not just wake you in the moment; the subsequent thermoregulatory activity and light sleep state can persist for 20 to 30 minutes after, meaning a woman with five nocturnal hot flashes is losing 1.5 to 2.5 hours of consolidated sleep per night.

The Perimenopause Sleep-Disruption Framework (WomanRx)

Perimenopausal night waking typically involves three overlapping mechanisms operating simultaneously:

1. Vasomotor: hot flash triggers arousal, thermoregulation prolongs waking
2. Neurochemical: falling estrogen reduces serotonin turnover, increasing anxiety-related lighter sleep
3. Circadian: progesterone loss removes GABA-A support for slow-wave sleep, shifting the sleep architecture toward lighter stages even on flash-free nights

Treating only one of these without addressing the others produces partial response. A woman whose hot flashes are controlled by menopause hormone therapy (MHT) but who still wakes at 3 a.m. Is likely experiencing the neurochemical or circadian component.

Post-Menopause

After the final menstrual period, estradiol stabilizes at a persistently low level rather than fluctuating. For many women, this actually reduces night-waking frequency relative to late perimenopause. However, the Menopause Society (formerly NAMS) 2023 position statement on MHT notes that sleep disruption remains prevalent in post-menopause and that vasomotor symptoms can persist for more than a decade after menopause in a significant minority of women. Genitourinary syndrome of menopause (GSM) also contributes: vaginal and urethral atrophy cause urinary urgency and nocturia that fragment sleep.

Thyroid Disorders and Night Waking

Thyroid dysfunction is underdiagnosed in women, who are five to eight times more likely than men to develop thyroid disease. Both poles of dysfunction disrupt sleep.

Hypothyroidism

Low thyroid hormone slows metabolic rate, often causing fatigue and hypersomnia rather than insomnia. But untreated hypothyroidism is also associated with sleep apnea (due to myxedema changes in upper airway tissue) and can produce a subjective sense of unrefreshing sleep with multiple awakenings. Women are more likely than men to present with atypical hypothyroid symptoms, including mood changes and sleep disruption as early or sole symptoms.

Hyperthyroidism and Subclinical Hyperthyroidism

Excess thyroid hormone raises resting heart rate, increases body temperature, and activates the sympathetic nervous system. All three mechanisms directly fragment sleep. Night waking from hyperthyroidism is often accompanied by palpitations, heat intolerance, and anxiety. Subclinical hyperthyroidism (low TSH with normal free T4 and T3) still carries these sleep effects and is more common in women taking thyroid replacement who are slightly over-replaced.

A TSH checked in isolation can miss a great deal. Ask your clinician for free T4 and free T3 alongside TSH if sleep disruption is unexplained after addressing other hormonal causes.

Blood Sugar and Insulin: An Underappreciated Cause

Hypoglycemia, even mild nocturnal dips that do not meet the clinical threshold for hypoglycemia, triggers a cortisol and adrenaline response that wakes you. This is particularly relevant for women with:

• PCOS with insulin resistance
• Type 1 or type 2 diabetes
• A history of gestational diabetes
• Those using GLP-1 receptor agonists (semaglutide, liraglutide), which reduce overnight glucose and can cause early-morning hypoglycemia in women also on insulin or sulfonylureas

A study in Diabetes Care documented that nocturnal glucose variability significantly predicts sleep fragmentation in women with type 2 diabetes. Eating a small protein-containing snack before bed or adjusting the timing of insulin with your endocrinologist may reduce these awakenings.

How Night Waking Is Diagnosed

Your clinician will approach this systematically. Self-reporting is important because most hormonal sleep disruption happens at home, not in a sleep lab. Here is what a thorough workup includes.

Symptom Diary: The Most Useful First Step

A two-week diary noting time to sleep, number of awakenings, what woke you (hot flash, anxiety, need to urinate, racing heart, no clear reason), daytime fatigue, and where you are in your menstrual cycle gives your clinician a pattern that no single lab value can match.

Laboratory Evaluation

Targeted labs depend on your history and life stage, but a reasonable first panel for unexplained night waking in a woman of any age includes:

| Test | What it rules in or out | |------|------------------------| | TSH, free T4 | Thyroid dysfunction | | Estradiol, FSH | Perimenopausal transition, premature ovarian insufficiency | | Progesterone (day 21 if cycling) | Luteal phase insufficiency | | Fasting glucose, insulin, HbA1c | Insulin resistance, glucose dysregulation | | Morning cortisol (8 a.m.) | HPA axis screening | | Complete blood count with iron studies | Iron deficiency (drives RLS and fatigue-related waking) |

Sleep Study Considerations

If you snore, have a bed partner who has observed pauses in your breathing, or have PCOS with obesity, a home sleep apnea test is appropriate before attributing everything to hormones. Women with sleep apnea are more likely than men to present with insomnia and night waking rather than loud snoring and excessive daytime sleepiness. The American Academy of Sleep Medicine notes that women are significantly under-referred for sleep studies, contributing to a diagnostic gap.

Treatment Options by Cause

Perimenopause and Menopause: Menopause Hormone Therapy

For women with vasomotor-driven night waking, MHT is the most effective treatment and is supported by the Menopause Society 2023 position statement for women under 60 or within 10 years of menopause onset without contraindications. Transdermal estradiol (patches, gels, sprays) combined with micronized progesterone (oral, 100-200 mg at bedtime) is the preferred formulation for sleep because oral progesterone taken at night produces measurable allopregnanolone levels that support slow-wave sleep. This is not true of synthetic progestins like medroxyprogesterone acetate. If you are using a synthetic progestin and still waking, the formulation may be part of the problem.

The Menopause Society states directly: "Hormone therapy remains the most effective treatment for vasomotor symptoms and is appropriate for healthy symptomatic women who are within 10 years of menopause or younger than 60 years."

Non-Hormonal Options for Perimenopausal Sleep

For women who cannot or prefer not to use MHT:

• Fezolinetant (Veozah): an FDA-approved neurokinin 3 receptor antagonist for vasomotor symptoms, shown in the SKYLIGHT 1 and 2 trials to reduce moderate-to-severe hot flash frequency by approximately 60% at 45 mg daily. Liver function monitoring is required.
• Low-dose paroxetine 7.5 mg (Brisdelle): the only SSRI with an FDA indication for vasomotor symptoms. It reduces hot flash frequency and may improve sleep continuity.
• Cognitive behavioral therapy for insomnia (CBT-I): the first-line treatment for insomnia regardless of cause per AASM guidelines, and specifically effective for perimenopausal insomnia. A meta-analysis in Sleep Medicine Reviews showed effect sizes for sleep maintenance comparable to pharmacological treatment with no rebound after discontinuation.

Thyroid-Related Waking

Optimizing thyroid replacement so your TSH sits in the lower half of the reference range (typically 0.5 to 2.0 mIU/L for symptomatic patients, per ATA guidance) resolves thyroid-mediated sleep disruption in most women within 6 to 12 weeks of dose stabilization.

Luteal Phase and Cycle-Linked Waking

Low-dose oral micronized progesterone (100 mg) taken in the luteal phase (days 14 to 28) is sometimes used off-label for luteal phase insomnia and is being studied more formally. It is not FDA-approved for this indication. Some women respond well; others find it causes morning grogginess. Your clinician should weigh this against your contraceptive needs, since luteal progesterone supplementation is not reliable contraception.

Who Is More Likely to Experience Hormonal Night Waking

You are at higher risk if you:

• Are between 40 and 55 (perimenopausal transition)
• Have PCOS at any age
• Have a personal or family history of thyroid disease
• Have a history of postpartum depression or premenstrual dysphoric disorder (PMDD), which signals sensitivity to hormonal fluctuations
• Are postpartum within the first year
• Have iron deficiency anemia
• Are undergoing fertility treatment with exogenous hormones
• Have a history of gestational diabetes or current insulin resistance

The overlap between these conditions is real. A woman with PCOS, insulin resistance, and elevated androgens may also be entering perimenopause early and dealing with subclinical hypothyroidism simultaneously. Each layer compounds the sleep disruption.

Pregnancy, Postpartum, and Lactation: What Is Safe

This section addresses treatment decisions specifically for pregnant, postpartum, and breastfeeding women.

During pregnancy: Most pharmacological sleep aids are not recommended. Melatonin has limited human safety data; a 2022 systematic review in Sleep Medicine Reviews found insufficient evidence to establish safety in pregnancy and noted theoretical concerns about melatonin's effects on fetal circadian development. CBT-I is the only intervention with a clear safety record for insomnia in pregnancy. Iron supplementation to treat deficiency is both safe and effective for RLS in pregnancy and should be first-line before any other approach.

Prescription sleep aids including zolpidem, eszopiclone, and benzodiazepines carry FDA pregnancy risk warnings and should be avoided except in exceptional circumstances under specialist supervision.

Postpartum and breastfeeding: Low-dose doxylamine (the antihistamine in Unisom) transfers into breast milk and may cause infant sedation; it is generally not recommended during breastfeeding. Melatonin is naturally present in breast milk, but supplemental doses and their effect on the nursing infant are not well studied. CBT-I, strategic napping, and having a support person handle one feeding per night remain the safest and most evidence-based interventions. If postpartum depression is present alongside insomnia, ACOG Practice Bulletin 214 supports sertraline or escitalopram as compatible with breastfeeding, and these antidepressants may also improve sleep continuity.

Contraception note for hormonal treatments: Micronized progesterone prescribed for luteal phase insomnia is NOT a reliable contraceptive. Women who are not trying to conceive and are taking any hormonal treatment for sleep should use a reliable contraceptive method concurrently unless they are confirmed post-menopausal or have a hormonal IUD or implant in place.

When to See a Clinician Urgently

Most hormonal night waking is not an emergency, but contact your clinician promptly if you are experiencing:

• Night sweats with unexplained weight loss, lymph node enlargement, or fever (these may signal lymphoma or other systemic illness, not perimenopause)
• Palpitations with night waking that feel irregular rather than simply fast
• Night waking accompanied by chest pressure or shortness of breath
• Sudden onset of severe insomnia after starting or changing a thyroid, hormonal, or psychiatric medication
• Night waking in pregnancy accompanied by reduced fetal movement